Fundraising Fox

Venaxis

Castle Rock, US · Nevada corporation

Healthtech

Founders & leadership

ST
Stephen T. LundyExecutive
JG
Jeffrey G. McGonegalExecutive

Board

DE
David E. WelchBoard director
SA
Stephen A. WilliamsBoard director
GS
Gail S. SchoettlerBoard director
DJ
Daryl J. FaulknerBoard director
SA
Susan A. EvansBoard director

Reported raises · per SEC filings

Form D private placements

$53M disclosed across 5 rounds · 2016–2019

▶$7.1MraisedFeb 2019 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Rob ChangExecutive Officer
  • Remo ManciniExecutive Officer
  • Jeffrey G. McGonegalExecutive Officer
  • Benjamin YiExecutive Officer
  • Jason LesExecutive Officer
Offering amount
$7.1M
Amount sold
$7.1M
First sale
Jan 2019
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$37MraisedDec 2017 · 32 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Eric SoDirector
  • Jason LesDirector
  • Jeffrey G. McGonegalExecutive Officer
  • John R. O'RourkeExecutive Officer, Director
  • Andrew KaplanDirector
Offering amount
$37M
Amount sold
$37M
Finders' fees
$500K
First sale
Dec 2017
Incorporated
Corporation, Nevada
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.3MraisedMar 2017 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeffrey G. McGonegalExecutive Officer
  • John R. O'RourkeDirector
  • Mike T. DaiDirector
  • Stephen T. LundyExecutive Officer, Director
  • Michael M. BeeghleyDirector
Offering amount
$2.3M
Amount sold
$2.3M
First sale
Mar 2017
Incorporated
Corporation, Colorado
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.8MraisedMar 2017 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mike T. DaiDirector
  • Jeffrey G. McGonegalExecutive Officer
  • Michael M. BeeghleyDirector
  • Stephen T. LundyExecutive Officer, Director
  • John R. O'RourkeDirector
Offering amount
$4.8M
Amount sold
$4.8M
Finders' fees
$200K
First sale
Mar 2017
Incorporated
Corporation, Colorado
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedSep 2016 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • David E. WelchDirector
  • Stephen A. WilliamsDirector
  • Gail S. SchoettlerDirector
  • Stephen T. LundyExecutive Officer, Director
  • Daryl J. FaulknerDirector
  • Susan A. EvansDirector
  • Jeffrey G. McGonegalExecutive Officer
Offering amount
$1.9M
Amount sold
$1.9M
First sale
Sep 2016
Incorporated
Corporation, Colorado
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Venaxis, Inc. To Present At ICV Company Outreach Summit - BioSpacebiospace.com · Jul 2014Medical Test Maker Venaxis, Inc. Banks $18.4 Million, Files For FDA Approval - BioSpacebiospace.com · Apr 2014What Every Investor Needs To Know About Venaxis, Inc. (NASDAQ:RIOT) | Seeking Alphaseekingalpha.com · Feb 2014

Frequently asked questions

How much funding has Venaxis raised?
Venaxis has disclosed $53M raised across 5 rounds.
Where is Venaxis headquartered?
Venaxis is headquartered in Castle Rock, US.